Skip to main content

Advertisement

Log in

The role of human Dectin-1 Y238X gene polymorphism in recurrent vulvovaginal candidiasis infections

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Recurrent vulvovaginal candidiasis (RVVC) is defined as having four or more symptomatic vulvovaginal candidiasis (VVC) attacks within a year. This study aimed to investigate whether Human Dectin-1 Y238X Gene Polymorphism plays a role in RVVC pathogenesis. In order to examine and explore this aim, an experimental study was undergone. The clinical study design was conducted with 50 women diagnosed with RVVC and had four or more symptomatic VVC attacks who were included in the experimental group; while 50 women who did not have previous RVVC history and diagnosis and did not have vaginal discharge and itching in the past year were included in the control group. Blood samples were collected from these patients and transferred to EDTA tubes, to investigate the Dectin-1 Y238X gene polymorphism, and stored at −80°. When Dectin-1 genotypes were compared, there was no significant difference between the two groups (p = 0.452, p = 0.615, p = 0.275). History of familial RVVC was significantly higher in the experimental group (p = 0.001). When the multivariate analysis was used to evaluate factors that could determine RVVC frequency, history of familial RVVC was found to increase the frequency of RVVC attacks by 3.3 units. This study is the first-of-its-kind to investigate the correlation between Dectin-1 Y238X polymorphism, which has not been previously studied in the Turkish population, and RVVC. The result of this study suggests that there is no correlation between this polymorphism and RVVC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fidel PL (2007) History and update on host defense against vaginal candidiasis. Am J Reprod Immunol 57:2–12

    Article  PubMed  Google Scholar 

  2. Ferrer J (2000) Vaginal candidosis: epidemiological and etiological factors. Int J Obstet Gynecol 71:21–27

    Article  Google Scholar 

  3. Goplerud CP, Ohm MJ, Galask R (1976) Aerobic and anaerobic flora of the cervix during pregnancy and the puerperium. Am J Obstet Gynecol 126:858–868

    CAS  PubMed  Google Scholar 

  4. Foxman B (1990) The epidemiology of vulvovaginal candidiasis: risk factors. Am J Public Health 80:329–331

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Leon EM, Jacober SJ, Sobel JD, Foxman B (2002) Prevalence and risk factors for vaginal candida colonization in women with type 1 and type 2 diabetes. BJM Infect Dis 2:1–4

    Article  Google Scholar 

  6. Donders GG, Prenen H, Verbeke G, Reybrouk R (2002) Impaired tolerance for glucose in women with recurent vaginal candidosis. Am J Obstet Gynecol 187:989–993

    Article  PubMed  Google Scholar 

  7. Bluestein D, Rutledge C, Lumsden L (2001) Predicting the occurrence of antibiotic-induced candidal vaginitis. Fam Pract Res 11:319–326

    Google Scholar 

  8. Galask RP (1988) Vaginal colonization by bacteria and yeast. Am J Obstet Gynecol 158:993–995

    Article  CAS  PubMed  Google Scholar 

  9. Hellberg D, Zdolsek B, Nilsson S, Mardh PA (1995) Sexual behaviorof women with repeated episodes of vulvovaginal candidiasis. Eur J Epidemiol 11:575–579

    Article  CAS  PubMed  Google Scholar 

  10. Mitchell H (2004) ABC of sexually transmitted infections. Vaginal discharge-causes, diagnosis and treatment. BMJ 328:1306–1308

    Article  PubMed Central  PubMed  Google Scholar 

  11. Magliani W, Conti S, Cassone A, De Bernardis F, Polonelli L (2002) New immunotherapeutic strategies to control vaginal candidiasis. Trends Mol Med 8:121–126

    Article  CAS  PubMed  Google Scholar 

  12. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, Spriel AB et al (2009) Human Dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Ramírez-Santos A, Pereiro MJr, Toribio J (2008) Recurrent vulvovaginitis: diagnostic assessment and therapeutic management. Actas Dermosifiliogr 99:190–198

    Article  PubMed  Google Scholar 

  14. Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6:33–43

    Article  CAS  PubMed  Google Scholar 

  15. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E et al (2004) Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104:4038–4045

    Article  CAS  PubMed  Google Scholar 

  16. Lefevre L, Lugo-Villarino G, Meunier E, Valentin A, Olagnier D, Authier H et al (2013) The C-type lectin receptors Dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum. Immunity 38:1–12

    Article  Google Scholar 

  17. Marakalala MJ, Vautier S, Potrykus J, Walker LA, Shepardson KM, Hopke A et al (2013) Differential adaptation of C. albicans in vivo modulates immune recognition by Dectin-1. PLoS Pathog 9:e1003315

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Çekirdekçioğlu N (2007) Immunology of candida infections. Turk J Infect 21:55–61

    Google Scholar 

  19. Schmidt-Weber CB, Akdis M, Akdis CA (2007) Th17 cells in the big picture of immunology. J Allergy Clin Immunol 120:247–254

    Article  CAS  PubMed  Google Scholar 

  20. Dennehy KM, Willment JA, Williams DL, Brown GD (2009) Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 39:1379–1386

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Ma J, Becker C, Lowell CA, Underhill DM (2012) Dectin-1- triggered recruitment of light chain 3 protein to phagosomes facilitates major histocompatibility complex class II presentation of fungal-derived antigens. J. Biol. Chem 287:34149–34156

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Brown GD, Gordon S (2001) Immune recognition a new receptor for betaglucans. Nature 413:36–37

    Article  CAS  PubMed  Google Scholar 

  23. Mueller A, Pretus H, Mc Namee R, Jones E, Browder I, Williams D (1995) Comparison of the carbohydrate biological response modifiers Krestin, Schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. J Chromatogr 666:283–290

    Article  CAS  Google Scholar 

  24. Maneu V, Yáñez A, Murciano C, Molina A, Gi ML, Gozalbo D (2011) Dectin-1 mediates in vitro phagocytosis of Candida. albicans yeast cells by retinal microglia. FEMS Immunol Med Microbiol 63(1):148–150

    Article  CAS  PubMed  Google Scholar 

  25. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H et al (2007) Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8:31–38

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM (2003) Collaborative induction of inflammatory responses by Dectin-1 and toll-like receptor 2. J Exp Med 197:1107–1117

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ (2008) Dectin-1 synergize with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol 10:2058–2066

    Article  CAS  PubMed  Google Scholar 

  28. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K et al (2007) Dectin-1 is required for host defense against Pneumocystis carini but not against Candida albicans. Nat Immunol 8:39–46

    Article  CAS  PubMed  Google Scholar 

  29. Plantinga T, Velden W, Ferwerd B, Spriel A, Adema G, Feuth T (2009) Early stop polymorphism in human dectin-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 49(5):724–732

    Article  CAS  PubMed  Google Scholar 

  30. Rosentul D, Delsing C, Joosten LAB, van der Meer JWM, Kullberg BJ, Netea MG (2009) Polymorphism in innate immunity genes and susceptibility to recurrent vulvovaginal candidiasis. De Mycol Med 19:191–196

    Article  Google Scholar 

  31. Clark SJ, Harrison J, Frommer M (1995) CpNpG methylation in mammalian cells. Nat Genet 10:20–27

    Article  CAS  PubMed  Google Scholar 

  32. Sobel JD (1997) Vaginitis. N Engl J Med 337:1896–1903

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Betul Usluogullari.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Usluogullari, B., Gumus, I., Gunduz, E. et al. The role of human Dectin-1 Y238X gene polymorphism in recurrent vulvovaginal candidiasis infections. Mol Biol Rep 41, 6763–6768 (2014). https://doi.org/10.1007/s11033-014-3562-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3562-2

Keywords

Navigation